Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Di Luch

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Opinion on Pharmacotherapy|February 28, 2026
Progress, potential and pitfalls of ketamine as a treatment for Depression and related disordersDiana K Orsini, Sara Di Luch, Gabrielle F M Lovell, et al.
Journal of Affective Disorders|December 31, 2025
A systematic review of ketamine and esketamine-induced long-term potentiation and synaptic scaling: Do the molecular and synaptic plasticity effects inform dosing intervals?Gia Han Le, Sabrina Wong, Danica E Johnson, et al.
Journal of Psychopharmacology (Oxford, England)|June 24, 2026
Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic reviewShreya Vasudeva, Gabrielle F M Lovell, Sabrina Wong, et al.
General Hospital Psychiatry|April 21, 2026
Evaluating the potential risk of ketamine-induced hepatotoxicity in the treatment of mood and anxiety disorders: A systematic reviewGabrielle F M Lovell, Shreya Vasudeva, Diana K Orsini, et al.
JAMA Psychiatry|April 15, 2026
Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic ReviewDiana K Orsini, Sabrina Wong, Sara Di Luch, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|February 28, 2026
Progress, potential and pitfalls of ketamine as a treatment for Depression and related disordersDiana K Orsini, Sara Di Luch, Gabrielle F M Lovell, et al.
Journal of Affective Disorders|December 31, 2025
A systematic review of ketamine and esketamine-induced long-term potentiation and synaptic scaling: Do the molecular and synaptic plasticity effects inform dosing intervals?Gia Han Le, Sabrina Wong, Danica E Johnson, et al.
Journal of Psychopharmacology (Oxford, England)|June 24, 2026
Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic reviewShreya Vasudeva, Gabrielle F M Lovell, Sabrina Wong, et al.
General Hospital Psychiatry|April 21, 2026
Evaluating the potential risk of ketamine-induced hepatotoxicity in the treatment of mood and anxiety disorders: A systematic reviewGabrielle F M Lovell, Shreya Vasudeva, Diana K Orsini, et al.
JAMA Psychiatry|April 15, 2026
Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic ReviewDiana K Orsini, Sabrina Wong, Sara Di Luch, et al.
Pageof 1